Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Apollo 18 ivs
IVS
Bankrupt
CVR 38352288
Østerbrogade 226, st. 1
Retail sale of fish, crustaceans and molluscs · NACE 4723
Est. 2017
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK 304K
+14% vs 2018
EBITDA margin
39.1%
+69% vs 2018
Equity ratio
2.4%
Financial strength
Net profit 2019
DKK 100K
+87% vs 2018
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
DKK 304K
+14%
EBITDA
DKK 119K
+69%
Net profit
DKK 100K
+87%
Total assets
DKK 41K
-31%
Equity
DKK 1K
-98%
Employees
—
—
Company information
Legal name
Apollo 18 ivs
CVR number
38352288
Legal form
Iværksætterselskab
NACE code
4723 · Retail sale of fish, crustaceans and molluscs
Founded
10. januar 2017
Share capital
DKK 1.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Østerbrogade 226, st. 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of fish, crustaceans and molluscs
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
Income statement
DKK thousands
Item
2017
2018
2019
Revenue
156
267
304
Staff expenses
-0
-0
-0
EBITDA
21
71
119
Depreciation & amort.
-0
-0
-0
EBIT
21
71
119
Net financials
0
0
0
Profit before tax
21
71
119
Tax
5
17
19
Net profit
16
54
100
Balance sheet
DKK thousands
Item
2017
2018
2019
Total assets
14
59
41
Equity
14
55
1
Long-term debt
0
0
0
Short-term debt
0
5
40
Total debt
0
5
40
Financial ratios
5-year trend
EBITDA margin
39.1%
This company
15.8%
Market median
+147% vs market
2017
2019
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
2017
2019
Return on equity
10045.0%
This company
18.4%
Market median
+54492% vs market
2017
2019
Net profit margin
33.0%
This company
8.1%
Market median
+307% vs market
2017
2019
Asset turnover
7.40×
This company
1.12×
Market median
+561% vs market
2017
2019
Debt / equity
40.09×
This company
0.62×
Market median
-6366% vs market
2017
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-10 – 2017-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Per Demsgaard Hansen
Individual
100%
100%
2019
Dorthe Hansen
Individual
100%
100%
2017
Danske IVS
Company
100%
100%
2018
Fiskepigen Aps
Company
100%
100%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Apollo 18 ivs also hold positions in
0
other companies.
Person
Role here
Other companies